Stockreport

BioCardia Regains Full Compliance with Nasdaq Listing Requirements

BioCardia, Inc.  (BCDA) 
PDF SUNNYVALE, Calif., Sept. 18, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of ca [Read more]